Source:http://linkedlifedata.com/resource/pubmed/id/15207318
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2004-6-21
|
pubmed:abstractText |
Pontine acetylcholine (ACh) contributes to the regulation of electroencephalographic and behavioral arousal in all mammals so far investigated. The mouse is recognized as a powerful model for pharmacogenomics but the synaptic mechanisms regulating ACh release in mouse pontine reticular formation have not been characterized. Drug delivery by microdialysis was used in isoflurane-anesthetized C57BL/6J (B6) mice (n=33) to test the hypothesis that muscarinic autoreceptors modulate ACh release in the pontine reticular nucleus, oral part (PnO). Dialysis delivery of tetrodotoxin to the PnO significantly decreased ACh by 58% below control levels, confirming that measured ACh reflected neurotransmitter release. The muscarinic antagonist scopolamine increased ACh release in the PnO by 21% (3 nM), 48% (10 nM), 56% (30 nM), and 104% (100 nM). The muscarinic agonist bethanechol dialyzed into the PnO significantly decreased ACh release by 60% compared with control. Dialysis delivery of relatively subtype selective muscarinic antagonists to the PnO revealed the following order of potency for increasing ACh release: scopolamine (3 nM)>AF-DX 116 (100 nM)=pirenzepine (100 nM). These data support the conclusion that ACh release in PnO of B6 mouse is modulated by non-M1 muscarinic receptors.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Acetylcholine,
http://linkedlifedata.com/resource/pubmed/chemical/Bethanechol,
http://linkedlifedata.com/resource/pubmed/chemical/Muscarinic Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Muscarinic Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Muscarinic,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrodotoxin
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0306-4522
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2004 IBRO
|
pubmed:issnType |
Print
|
pubmed:volume |
126
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
831-8
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:15207318-Acetylcholine,
pubmed-meshheading:15207318-Analysis of Variance,
pubmed-meshheading:15207318-Animals,
pubmed-meshheading:15207318-Bethanechol,
pubmed-meshheading:15207318-Dose-Response Relationship, Drug,
pubmed-meshheading:15207318-Male,
pubmed-meshheading:15207318-Mice,
pubmed-meshheading:15207318-Mice, Inbred C57BL,
pubmed-meshheading:15207318-Microdialysis,
pubmed-meshheading:15207318-Muscarinic Agonists,
pubmed-meshheading:15207318-Muscarinic Antagonists,
pubmed-meshheading:15207318-Receptors, Muscarinic,
pubmed-meshheading:15207318-Reticular Formation,
pubmed-meshheading:15207318-Tetrodotoxin
|
pubmed:year |
2004
|
pubmed:articleTitle |
Acetylcholine release in the pontine reticular formation of C57BL/6J mouse is modulated by non-M1 muscarinic receptors.
|
pubmed:affiliation |
Departments of Anesthesiology and Pharmacology, University of Michigan, 7433 Medical Sciences Building I, 1150 West Medical Center Drive, Ann Arbor, MI 48109-0615, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.
|